Fundz

HeartBeam, Inc. announced a public offering to raise $10 million by selling common stock at $1.70 per share, with MDB Capital acting as the underwriter.

PUBLIC · BEATFeb 13, 2025

Amount Raised

$10 Million

Round Type

Post-IPO Equity

Santa ClaraHealthcare

Investors

Paulson Investment Company LlcMDB Capital

Description

HeartBeam, Inc. has priced its public offering of 5,882,353 shares of common stock at $1.70 per share, expecting to close the offering around February 14, 2025. The funding will support the company’s strategic plan and preparation for U.S. commercialization.

Quick answer

HeartBeam, Inc. raised $10 Million in a Post-IPO Equity round, dated February 13, 2025. Investors: Paulson Investment Company Llc and MDB Capital. HeartBeam, Inc. is based in Santa Clara, California, United States.

How much did HeartBeam, Inc. raise?
HeartBeam, Inc. raised $10 Million in a Post-IPO Equity round on February 13, 2025.
Who invested in HeartBeam, Inc?
Paulson Investment Company Llc and MDB Capital are named as investors in this round.
What does HeartBeam, Inc. do?
HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions.
Where is HeartBeam, Inc. based and how big is it?
HeartBeam, Inc. is based in Santa Clara, California, United States. Fundz records about 21 employees.
Who are the decision-makers at HeartBeam, Inc?
Fundz holds 2 contacts at HeartBeam, Inc., including the Chief Technology Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as HeartBeam, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Hummingbird Healthcare raised $20M (Series B) on February 21, 2025.
  • Hummingbird Healthcare raised $19M on February 14, 2025.
  • Eliaz Therapeutics raised $850K (Seed) on March 28, 2025.
  • Imagen Dental Partners raised $954K on March 28, 2025.
  • NewcelX raised $2M (Seed) on March 28, 2025.
  • SetPoint Medical raised $115M on March 27, 2025.

Who to call at HeartBeam, Inc., and when

A new round usually means HeartBeam, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day HeartBeam, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at HeartBeam, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at HeartBeam, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

HeartBeam, Inc.

Location

2118 WALSH AVE., SUITE 210

Santa Clara, California, United States

About

HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The Company is creating the first ever cable-free device capable of collecting ECG signals in 3D, from 3 non-co-planar directions, and synthesizing the signals into a 12-lead ECG. This platform technology is designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care – all outside of a medical facility, thus redefining the future of cardiac health management. HeartBeam’s 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment HeartBeam, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsKen P., Chief Technology Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for HeartBeam, Inc.'s next move

See what Strategic adds

HeartBeam, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.